 |
市場調査レポート
商品コード
1452716
気管支拡張薬の世界市場規模、シェア、成長分析、薬剤タイプ別、投与経路別 - 産業予測（2024-2031年）Global Bronchodilators Market Size, Share, Growth Analysis, By Drug Type(Beta2-Adrenergic Agonists, Sympathomimetics), By Route of Administration(Oral, Injection) - Industry Forecast 2024-2031 |
||||||
| 気管支拡張薬の世界市場規模、シェア、成長分析、薬剤タイプ別、投与経路別 - 産業予測（2024-2031年） |
|
出版日: 2024年03月11日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
気管支拡張剤の世界市場規模は2022年に221億9,000万米ドルと評価され、2023年の234億8,000万米ドルから2031年には368億6,000万米ドルに成長し、予測期間（2024～2031年）はCAGR5.8%で推移する見通しです。
気管支拡張薬市場は、気管支炎、喘息、慢性閉塞性肺疾患（COPD）などの呼吸器疾患の罹患率の増加により、大幅に拡大しています。気管支拡張薬として知られる薬は、肺の気道を広げ弛緩させて呼吸を容易にします。気管支拡張薬の需要は、様々な呼吸器疾患の世界的な負担増加や、環境変数やライフスタイルの変化によって高まっています。市場で入手可能な気管支拡張薬には、短時間作用型と長時間作用型の2種類があり、それぞれが患者にとって明確な目的を果たします。長時間作用型の気管支拡張薬は慢性的な治療に長期的な効果をもたらしますが、短時間作用型の気管支拡張薬は急性の呼吸器疾患に対して即効的な緩和をもたらします。呼吸器疾患の罹患率が高く、ヘルスケアシステムが発達し、意識が高まっているため、北米と欧州が大きな市場シェアを占めています。人口密集地では汚染レベルが上昇し、ライフスタイルが変化しているため、アジア太平洋地域は貴重な市場になりつつあります。さらに、ドライパウダー吸入器や定量吸入器のような吸入デバイスの改良により、患者のコンプライアンスと薬物送達の有効性が向上しています。気管支拡張剤市場は、呼吸器疾患の有病率の上昇に伴い、さらに成長すると予想されます。この成長は、継続的な研究、独創的な投薬処方、製薬部門内の巧みなパートナーシップによって促進されます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
気管支拡張薬の世界市場：薬剤タイプ別
- 市場概要
- ベータ2アドレナリン作動薬
- 交感神経模倣薬
- 抗コリン薬
- ホスホジエステラーゼ阻害剤
- 配合剤
気管支拡張薬の世界市場：投与経路別
- 市場概要
- オーラル
- 注射
- 吸入器
気管支拡張薬の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Teva Pharmaceutical Industries
- Novartis
- Merck & Co.
- Mylan N.V.
- Sunovion Pharmaceuticals
- Cipla
- Vectura Group
- Chiesi Farmaceutici
- Mundipharma
- Perrigo
- Orion Corporation
- Almirall
Global Bronchodilators Market size was valued at USD 22.19 billion in 2022 and is poised to grow from USD 23.48 billion in 2023 to USD 36.86 billion by 2031, growing at a CAGR of 5.8% during the forecast period (2024-2031).
The market for bronchodilators is expanding significantly as a result of the increased incidence of respiratory conditions such bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Medication known as a bronchodilator widens and relaxes the lungs' airways to facilitate breathing. The demand for bronchodilator drugs is being driven by the rising global burden of various respiratory illnesses, as well as by changing environmental variables and lifestyles. The two types of bronchodilators available on the market are short-acting and long-acting, with each serving a distinct purpose for patients. While long-acting bronchodilators give prolonged benefits for chronic treatment, short-acting bronchodilators offer immediate relief during acute respiratory issues. Due to a high incidence of respiratory illnesses, a developed healthcare system, and growing awareness, North America and Europe control significant market shares. Because of rising pollution levels and changing lifestyles in densely populated areas, the Asia-Pacific region is becoming a valuable market. Furthermore, improvements in inhalation devices-like dry powder inhalers and metered-dose inhalers-are improving patient compliance and the effectiveness of medication delivery. The market for bronchodilators is expected to grow further as the prevalence of respiratory conditions rises. This growth will be fueled by ongoing research, creative medication formulations, and clever partnerships within the pharmaceutical sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bronchodilators Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bronchodilators Market Segmental Analysis
Based on Indication, Drug Type, Route of Administration, and Region, the global market for bronchodilators is divided into segments. The market is divided into categories based on indication, including asthma, chronic obstructive pulmonary disease (COPD), and others. The market is divided into four segments based on the kind of drug: combination bronchodilators, beta2-adrenergic antagonists, anticholinergic agents, and methylxanthines. The market is divided into oral, injection, and inhaler segments based on the route of administration. The market is divided into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa based on region.
Drivers of the Global Bronchodilators Market
The market for bronchodilators is mostly driven by the rising prevalence of respiratory conditions such bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Effective bronchodilator drugs are required for both disease management and symptom alleviation because to the increasing global burden of these illnesses.
Restraints in the Global Bronchodilators Market
Certain bronchodilators, especially those that are breathed, may cause side effects such headaches, tremors, and elevated heart rate. These side effects may cause patients to stop using the medication consistently or to stop following their treatment plans.
Market Trends of the Global Bronchodilators Market
One essential part of administering bronchodilators is using inhalation devices. Advanced inhaler technologies, such smart inhalers and digital monitoring systems, are becoming more and more popular in the market. These developments improve treatment adherence and illness management by providing real-time drug consumption monitoring and feedback to patients and medical providers.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Bronchodilators Market by Drug Type
- Market Overview
- Beta2-Adrenergic Agonists
- Sympathomimetics
- Anticholinergics
- Phosphodiesterase Inhibitor
- and Combination Drugs.
Global Bronchodilators Market by Route of Administration
- Market Overview
- Oral
- Injection
- and Inhaler.
Global Bronchodilators Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sunovion Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vectura Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Chiesi Farmaceutici
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mundipharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perrigo
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orion Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Almirall
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
